Vemurafenib reverses immunosuppression by myeloid derived suppressor cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Vemurafenib reverses immunosuppression by myeloid derived suppressor cells

Published:2013-04-13 Issue:7 Volume:133 Page:1653-1663
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Schilling Bastian¹,Sucker Antje¹,Griewank Klaus¹,Zhao Fang¹,Weide Benjamin²,Görgens André³,Giebel Bernd³,Schadendorf Dirk¹,Paschen Annette¹

Affiliation:

1. Department of Dermatology; University Hospital; University Duisburg-Essen; Essen, Germany

2. Department of Dermatology; University Medical Center; University of Tübingen; Tübingen; Germany

3. Institute of Transfusion Medicine; University Hospital; University Duisburg-Essen; Essen, Germany

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference42 articles.

1. Human T cell responses against melanoma;Boon;Annu Rev Immunol,2006

2. Immature immunosuppressive CD14+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign;Poschke;Cancer Res,2010

3. Fine analysis of spontaneous MAGE-C1/CT7-specific immunity in melanoma patients;Nuber;Proc Natl Acad Sci USA,2010

4. Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine;Filipazzi;J Clin Oncol,2007

5. Overcoming immunosuppression in the melanoma microenvironment induced by chronic inflammation;Umansky;Cancer Immunol Immunother,2012

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploiting temporal aspects of cancer immunotherapy;Nature Reviews Cancer;2024-06-17

2. Tumor-targeted therapy with BRAF-inhibitor recruits activated dendritic cells to promote tumor immunity in melanoma;Journal for ImmunoTherapy of Cancer;2024-04

3. Myeloid-derived suppressor cells in cancer and cancer therapy;Nature Reviews Clinical Oncology;2024-01-08

4. Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target;Journal of Clinical Investigation;2023-07-03

5. Kinase inhibitors: Opportunities for small molecule anticancer immunotherapies;Drug Discovery Today;2023-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3